Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Researchers identified 4 prepregnancy conditions that were associated with better pregnancy outcomes among patients with SLE.

Medicare covers lupus treatment in different ways depending on your age and how the condition affects you. Read more.

Visit Exec Edge Research for Full Report By Exec Edge Research Climb Bio, Inc. (Nasdaq: CLYM) reported full-year results, ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Nkarta is laying off a third of its employees, including half of the biotech’s executive leadership, as the company diverts ...

Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect ...

Eligible Lancashire residents are being invited to book their spring Covid-19 vaccine, as the NHS warns the virus can still ...

Stock analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Artiva Biotherapeutics in a research note issued on Wednesday, March 26th. HC Wainwright analyst E. White now ...

Initial data for AlloNK® from autoimmune program expected H1 2025 Updated clinical data from Phase 1/2 trial exploring AlloNK ...